Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
J Intern Med. 2012 May;271(5):490-8. doi: 10.1111/j.1365-2796.2011.02465.x. Epub 2011 Oct 31.
Phospholipid transfer protein (PLTP) is an emerging cardiometabolic risk marker that is important in high-density lipoprotein (HDL) and triglyceride metabolism. Plasma PLTP activity is elevated in type 2 diabetes mellitus, whereas glucose may regulate PLTP gene transcription in vitro. Of interest, common PLTP variations that predict cardiovascular disease have been identified recently. We investigated whether the diabetic state is able to amplify relationships between obesity and PLTP gene variations with circulating PLTP levels.
Plasma PLTP activity (using a phospholipid vesicles-HDL system), PLTP gene score [number of PLTP activity-decreasing alleles based on two tagging polymorphisms (rs378114 and rs60- 65904)] and waist circumference were determined in two Dutch cohorts comprising 237 patients with type 2 diabetes and 78 control subjects.
Patients with diabetes were more obese (P < 0.001 for prevalence of increased waist circumference) and had 13% higher plasma PLTP activity (P < 0.001). PLTP gene score was not different in diabetic and control subjects (P = 0.40). PLTP activity was highest in patients with diabetes with an enlarged waist and lowest in control subjects with a normal waist circumference (P < 0.001). Multiple linear regression analysis revealed a positive interaction between diabetes status and waist circumference on PLTP activity (β = 0.200, P = 0.005). Furthermore, diabetes status (β = -0.485, P = 0.046) or HbA1c (β = -0.240, P = 0.035) interacted with PLTP gene score to affect PLTP activity.
Type 2 diabetes and enlarged waist circumference interact to impact on plasma PLTP activity. Diabetes may also amplify the association between plasma PLTP activity and common PLTP gene variations. Our findings support the hypothesis that diabetes-environment and diabetes-gene interactions govern plasma PLTP activity.
磷脂转移蛋白 (PLTP) 是一种新兴的代谢风险标志物,在高密度脂蛋白 (HDL) 和甘油三酯代谢中发挥重要作用。2 型糖尿病患者的血浆 PLTP 活性升高,而体外葡萄糖可能调节 PLTP 基因转录。有趣的是,最近已经确定了预测心血管疾病的常见 PLTP 变异。我们研究了糖尿病状态是否能够放大肥胖与 PLTP 基因变异与循环 PLTP 水平之间的关系。
在两个荷兰队列中,包括 237 例 2 型糖尿病患者和 78 例对照,测定了血浆 PLTP 活性(使用磷脂囊泡-HDL 系统)、PLTP 基因评分[基于两个标记多态性(rs378114 和 rs60-65904)的 PLTP 活性降低等位基因数]和腰围。
糖尿病患者更肥胖(腰围增大的患病率差异具有统计学意义,P<0.001),血浆 PLTP 活性高 13%(P<0.001)。糖尿病患者和对照组的 PLTP 基因评分无差异(P=0.40)。腰围增大的糖尿病患者的 PLTP 活性最高,腰围正常的对照组的 PLTP 活性最低(P<0.001)。多元线性回归分析显示,糖尿病状态和腰围对 PLTP 活性有正交互作用(β=0.200,P=0.005)。此外,糖尿病状态(β=-0.485,P=0.046)或糖化血红蛋白(β=-0.240,P=0.035)与 PLTP 基因评分相互作用影响 PLTP 活性。
2 型糖尿病和腰围增大相互作用影响血浆 PLTP 活性。糖尿病也可能放大 PLTP 活性与常见 PLTP 基因变异之间的关联。我们的发现支持这样一种假设,即糖尿病-环境和糖尿病-基因相互作用控制着血浆 PLTP 活性。